SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Total 13F shares
204,003,018
Share change
+32,718,348
Total reported value
$180,750,718
Put/Call ratio
154%
Price per share
$0.89
Number of holders
212
Value change
+$27,197,640
Number of buys
100
Number of sells
76

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2022

As of 31 Dec 2022, SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by 212 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 204,003,018 shares. The largest 10 holders included STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, B. Riley Financial, Inc., B. Riley Securities, Inc., D. E. Shaw & Co., Inc., Rafferty Asset Management, LLC, NORTHERN TRUST CORP, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 212 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.